文献速递产科母胎医学

1级高血压孕妇的风险特征:时间事件分析

Defining the risk profile of women with stage 1 hypertension: a time to event analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-04-18

这项回顾性队列研究纳入2014至2016年单胎妊娠孕妇3000例,按孕20周前血压分为正常、1级高血压和2级高血压三组。1级高血压孕妇发生妊娠期高血压疾病的风险是正常血压者的2倍,且诊断孕周更早,但病情较2级高血压者更轻。

要点

  • 1级高血压孕妇发生妊娠期高血压疾病风险约为正常血压者的2倍。
  • 1级高血压孕妇诊断妊娠期高血压疾病的孕周显著早于正常血压者。
  • 1级高血压者的妊娠期高血压疾病表型较2级高血压者更轻,母儿并发症风险更低。

核心结论

  • 1级高血压孕妇较正常血压者更早发生妊娠期高血压疾病,但病情偏向较轻类型。
  • 与2级高血压孕妇相比,1级高血压者的妊娠期高血压疾病表型更轻,母儿并发症风险显著更低。

研究设计与样本

  • 单中心回顾性队列研究,纳入2014至2016年单胎妊娠孕妇共3000例。
  • 按孕20周前血压分为正常血压组(<130/80 mm Hg)、1级高血压组(130-139/80-89 mm Hg)和2级高血压组(≥140/90 mm Hg或有慢性高血压史)。
  • 主要结局为发生妊娠期高血压疾病的时间,采用Kaplan-Meier曲线和log-rank检验比较,并用Cox比例风险模型校正年龄、种族和民族、孕前糖尿病及体重指数。

主要发现

  • 正常血压组2370例(79.0%),1级高血压组315例(10.5%),2级高血压组315例(10.5%)。
  • 诊断妊娠期高血压疾病的孕周中位数:正常血压组38.7周(37.0-39.7),1级高血压组38.0周(36.4-39.4),2级高血压组36.4周(33.7-37.8),P<.001。
  • 仅分析重度子痫前期患者时,上述孕周差异同样存在。
  • 1级高血压孕妇发生妊娠期高血压疾病的风险是正常血压者的2倍。

临床怎么用

  • 对孕早期1级高血压孕妇应加强产前咨询,告知其妊娠期高血压疾病风险升高且可能更早发生。
  • 对1级高血压孕妇需制定近足月及产后的监测和随访计划。

局限性

  • 本研究为单中心回顾性队列研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hypertension complicates up to 5% of pregnancies and is increasing in prevalence. Women with hypertension have increased risks of serious maternal morbidity and mortality in pregnancy, including the development of preeclampsia. In 2017, new guidelines reclassified blood pressure into the following 4 categories: normal (<120/<80 mm Hg), elevated (120-129/<80 mm Hg), stage 1 hypertension (130-139/80-89 mm Hg), and stage 2 hypertension (>140/>90 mm Hg). This new classification doubles the number of reproductive-aged women with hypertension. Furthermore, studies have demonstrated that women entering pregnancy with stage 1 hypertension have an increased risk of developing hypertensive disorders of pregnancy compared with their normotensive counterparts, but the time course to the development of hypertensive disorders of pregnancy in these women remains uncertain. OBJECTIVE: We sought to evaluate the risk of developing a hypertensive disorder of pregnancy and the time to the development of these disorders in women with stage 1 hypertension vs both normotensive women and those with stage 2 hypertension. STUDY DESIGN: This was a retrospective cohort study of all patients from a single tertiary care center with singleton gestations from 2014 to 2016. Patients at prenatal visits before 20 weeks of gestation were classified into 3 blood pressure groups: normotensive (<130/80 mm Hg), stage 1 hypertension (130-139/80-89 mm Hg), or stage 2 hypertension (≥140/90 or a history of chronic hypertension). The primary outcome, time to the development of a hypertensive disorder of pregnancy, was compared among groups using Kaplan-Meier curves and the log-rank test. Cox proportional-hazards models were used to adjust for age, race and ethnicity, pregestational diabetes mellitus, and body mass index. In addition, multiple secondary obstetrical, maternal, and neonatal outcomes were assessed. RESULTS: Of the 3000 women in our cohort, 2370 (79.0%) were categorized in the normotensive group, 315 (10.5%) were categorized in the stage 1 hypertension group, and 315 (10.5%) were categorized in the stage 2 hypertension group. The gestational age at diagnosis was significantly earlier in gestation among blood pressure groups (normotensive [38.7 (37.0-39.7)] vs stage 1 hypertension [38.0 (36.4-39.4)] vs stage 2 hypertension [36.4 (33.7-37.8)]; P<.001). When the analysis was restricted to only those patients diagnosed with preeclampsia with severe features, the same findings were observed. Women with stage 1 hypertension exhibited a 2-fold increased risk of developing hypertensive disorders of pregnancy compared with normotensive women. Compared with women with stage 2 hypertension, women with stage 1 hypertension exhibited a milder phenotype of hypertensive disorders of pregnancy and exhibited significantly less risk of maternal and neonatal morbidities. CONCLUSION: Women with stage 1 hypertension are at increased risk of developing hypertensive disorders of pregnancy at earlier gestational ages compared with normotensive women; however, their development of a hypertensive disorder of pregnancy is skewed toward milder diseases compared with women with stage 2 hypertension. These new insights into the graded risk profile of obstetrical hypertensive diseases associated with new blood pressure categories can better inform our antepartum counseling and monitoring and surveillance plans near term and in the postpartum period.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Sabol BA, Porcelli B, Diveley E, et al. Defining the risk profile of women with stage 1 hypertension: a time to event analysis. Am J Obstet Gynecol MFM. 2021. PMID: 33878494. doi:10.1016/j.ajogmf.2021.100376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。